Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival: An Observational Study
Topic overview
Retrospective study of 50 hepatoblastoma patients demonstrates that achieving no evidence of disease status through aggressive surgical intervention—including repeated pulmonary metastasectomies—significantly improves 10-year survival. High-risk patients achieved similar outcomes to standard-risk when NED was attained, supporting aggressive surgical strategies for local and metastatic disease control.
Key takeaways
- Achieving no evidence of disease (NED) status dramatically reduces 5-year mortality in hepatoblastoma (OR 0.006, P<0.01).
- High-risk patients achieve similar 10-year survival to standard-risk when NED is attained through aggressive surgical intervention.
- Repeated pulmonary metastasectomy (median 2.5 procedures) enables long-term survival even in bilateral metastatic disease.
- 82% of hepatoblastoma patients were rendered NED through persistent surgical resection of residual and metastatic disease.
- Three of five high-risk relapsed patients were successfully salvaged, supporting continued aggressive treatment at recurrence.
Comments